Literature DB >> 18667440

c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development.

You-Chin Lin1, Ming-Wei Kuo, John Yu, Huan-Hsien Kuo, Ruey-Jen Lin, Wan-Lin Lo, Alice L Yu.   

Abstract

Human c-Myb proto-oncogene is highly expressed in hematopoietic progenitors as well as leukemia and certain solid tumor. However, the regulatory mechanisms of its expression and biological functions remain largely unclear. Recently, c-Myb has been shown to be targeted by microRNA-150 (miR-150) which thereby controls B cell differentiation in mice. In this study, we demonstrated that c-Myb is an evolutionary conserved target of miR-150 in human and zebrafish, using reporter assays. Ectopic expression of miR-150 in breast cancer and leukemic cells repressed endogenous c-Myb at both messenger RNA (mRNA) and protein levels. Among several leukemia cell lines, primary leukemia cells, and normal lymphocytes, expression levels of miR-150 inversely correlated with c-Myb. The miR-150 overexpression or c-Myb silencing in zebrafish zygotes led to similar and serious phenotypic defects in zebrafish, and the phenotypic aberrations induced by miR-150 could be reversed by coinjection of c-Myb mRNA. Our findings suggest that c-Myb is an evolutionally conserved target of miR-150 and miR-150/c-Myb interaction is important for embryonic development and possibly oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667440     DOI: 10.1093/molbev/msn165

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  41 in total

Review 1.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

3.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

4.  A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice.

Authors:  Fei Tang; Peng Zhang; Peiying Ye; Christopher A Lazarski; Qi Wu; Ingrid L Bergin; Timothy P Bender; Michael N Hall; Ya Cui; Liguo Zhang; Taijiao Jiang; Yang Liu; Pan Zheng
Journal:  Elife       Date:  2017-12-05       Impact factor: 8.140

5.  MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.

Authors:  Chia-Hao Tung; Li-Wei Kuo; Meng-Fan Huang; Yi-Ying Wu; Yao-Tsung Tsai; Jia-En Wu; Keng-Fu Hsu; Yuh-Ling Chen; Tse-Ming Hong
Journal:  Oncogene       Date:  2019-09-30       Impact factor: 9.867

Review 6.  MicroRNAs of the immune system: roles in inflammation and cancer.

Authors:  Jan Davidson-Moncada; F Nina Papavasiliou; Wayne Tam
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 7.  Small players with big roles: microRNAs as targets to inhibit breast cancer progression.

Authors:  Stephanie B Greene; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  Curr Drug Targets       Date:  2010-09       Impact factor: 3.465

8.  miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.

Authors:  Zeyu Chen; Erietta Stelekati; Makoto Kurachi; Sixiang Yu; Zhangying Cai; Sasikanth Manne; Omar Khan; Xiaolu Yang; E John Wherry
Journal:  Cell Rep       Date:  2017-09-12       Impact factor: 9.423

9.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis.

Authors:  Changsheng Du; Chang Liu; Jiuhong Kang; Guixian Zhao; Zhiqiang Ye; Shichao Huang; Zhenxin Li; Zhiying Wu; Gang Pei
Journal:  Nat Immunol       Date:  2009-10-18       Impact factor: 25.606

10.  The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site.

Authors:  Audrey Guillon-Munos; Ginette Dambrine; Nicolas Richerioux; Damien Coupeau; Benoît Muylkens; Denis Rasschaert
Journal:  BMC Mol Biol       Date:  2010-09-02       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.